VR Logo
Value Research Stocks

Astrazeneca Pharma India Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

37 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

Get the Stocks!

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1979

Chairman: Narayan K Seshadri

Managing Director: Gagandeep Singh Bedi

Group: Astrazeneca Pharma India - MNC

Listing: NSE: ASTRAZEN, BSE: 506820

Headquarters: Bengaluru, Karnataka

Website: www.astrazenecaindia.com

Key Facts

Market cap: R 6,221.13 Cr

Revenue (TTM): R 818.54 Cr

Earnings (TTM): R 74.85 Cr

Cash: R 173.30 Cr

Total Debt: R 0.00 Cr

Promoters' ownership: 75.00%

Liquidity: High

52 Week range: R 1,570.00 - 2,931.85

Face value: R2.00

Shares outstanding: 2,50,00,000

Stock Performance

Time Period Astrazeneca Pharma India * *
YTD-4.79----
1 month-10.52----
3 months9.34----
1 Year55.30----
3 Years36.56----
5 Years23.48----
10 Years10.96----
As on 20-Jan-2020 *As on
Year Astrazeneca Pharma India S&P BSE Small Cap S&P BSE Healthcare
201981.26-6.85-3.55
201824.22-23.41-5.89
201726.0059.640.49
2016-26.411.77-12.88
201543.316.7615.06
20142.9469.2447.43
2013-37.81-11.2322.55